American College of Cardiology

DECEMBER 19, 2023

Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology. This year saw exciting developments in the treatment of pediatric and congenital heart disease.

Congenital 67

Congenital Pediatrics Congenital Heart Disease Interventional Cardiology 67

Dr. Smith's ECG Blog

JUNE 17, 2024

He was started on a heparin drip and CTA of the chest was ordered to rule out pulmonary embolism. This is a case like many others posted (see list below) and the EKG from the patient’s original presentation can be quickly recognized as diagnostic for pulmonary embolism. In fact, Kosuge et al. Accessed May 28, 2024. This is a quiz.

Chest Pain 139

Chest Pain Embolism Pulmonary Tachycardia 139

Society of Thoracic Surgeons - Allied Health

NOVEMBER 15, 2022

Event 2023 STS Coding Workshop kchalko Tue, 11/15/2022 - 16:12 Event dates Feb 10–11, 2023 Location Virtual Registrants : To access the library of on-demand content, log into the STS Learning Center. Then go to “In Progress” courses on the dashboard or look in the “My Activities” tab. Missed the event? STS Members receive a discount!

Reimbursement 52

Reimbursement Cardiothoracic Document Congenital 52

DAIC

FEBRUARY 14, 2025

i The TAILORED-AF clinical trialis the first large-scale transatlantic randomized controlled trial (RCT) of ablation in a persistent atrial fibrillation (AF) population to show the benefit of going beyond conventional pulmonary vein isolation (PVI)-only extra-pulmonary vein procedure. tim.hodson Fri, 02/14/2025 - 09:57 Feb.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

Background Pulmonary hypertension (PH) is linked to higher rates of morbidity and mortality worldwide. The estimated pulmonary artery systolic pressure (ePASP ≥ 35 mmHg) measured by echocardiography helps screen PH patients. Early diagnosis of PH is important for clinical treatment.

Pulmonary 64

Pulmonary Hypertension Hospital Outcomes 64

DAIC

FEBRUARY 6, 2024

Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. AFib is the most common heart rhythm disorder, affecting more than 30 million patients worldwide.

Ablation 104

Ablation Atrial Fibrillation AFIB Pulmonary 104

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Patients in Group 2 had greater pulmonary artery systolic pressure than those in Group 1 (p-value<0.001). The patients were divided into two groups based on age: Group 1 included children and adolescents (18 years of age; n=42), while Group 2 consisted of adults (>18 years of age; n=57), at the time of device percutaneous closure.

Hospital 52

Hospital Exercise Tachycardia Pulmonary 52

HeartRhythm

APRIL 30, 2024

We previously reported that first-pass pulmonary vein (PV) isolation (FPI) is related to the PV isolation (PVI) durability in ablation index (AI) guided catheter ablation for atrial fibrillation (AF) (J Cardiovasc Electrophysiol 2023). However, the impact of obesity on FPI has been scarcely reported.

Obesity 40

Obesity Pulmonary Ablation Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

MARCH 17, 2025

Methods and Results A total of 323 consecutive FAT patients who underwent electrophysiological study and radiofrequency catheter ablation between January 2011 and March 2023 were selected for this study. Young adults had a higher proportion of FAT originating from the superior vena cava and pulmonary veins.

Tachycardia 40

Tachycardia Ablation Outcomes Tricuspid 40

DAIC

JANUARY 31, 2024

A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., The FARAPULSE PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e.,

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

Frontiers in Cardiovascular Medicine

MAY 13, 2024

Due to the implantation technique, left pulmonary artery (LPA) stents represent a relative contraindication to Venus P-valve. 16/17 (94%) patients were successfully implanted. 3/16 (18.7%) patients underwent Venus P-valve implantation with LPA stents.

Stents 52

Stents Stent Pulmonary 52

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.

Pulmonary 40

Pulmonary Atrial Fibrillation Hypertension Heart Disease 40

Dr. Smith's ECG Blog

SEPTEMBER 23, 2024

In patients with narrow QRS ( not this patient), this pattern is highly suggestive of acute pulmonary embolism. Although it was technically difficult and the quality therefore leaves a lot to be desired, you can still make out RV dilation and septal flattening which is much more suggestive of pulmonary embolism than OMI.

Cardiogenic Shock 128

Cardiogenic Shock Ultrasound Tachycardia Pulmonary 128

DAIC

MARCH 28, 2024

The VARIPULSE Platform is designed to enable pulmonary vein isolation with the versatility of a catheter loop, a simple generator user interface, and a mapping system that provides an intuitive, reproducible workflow with real-time visualization, contact indicator, and PF tagging mechanisms. In the U.S., doi: 10.1016/j.jacc.2014.04.072

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

Circulation

NOVEMBER 11, 2024

However, retrograde arterial perfusion from the femoral artery can increase left ventricular (LV) afterload, resulting in LV distention which may hamper myocardial recovery and worsen pulmonary congestion. Impella may be particularly effective in reducing pulmonary congestion. 3.65]; p&lt;0.0001). to 1.96) and VA-ECMO alone (1.94

Cardiogenic Shock 40

Cardiogenic Shock Pulmonary Aortic Circulation 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR‐21.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Circulation

NOVEMBER 11, 2024

Background:Transcatheter pulmonary valve replacement (TPVR) has been acknowledged as a common and beneficial treatment for significant pulmonary regurgitation (PR), but data are still lacking about the mid-term effects of self-expanding valve implantation in patients with pyramidal right ventricular outflow tract (RVOT).Methods:This

Pulmonary 40

Pulmonary Outcomes Circulation 40

Heart 2023 Conference

APRIL 20, 2022

JACC: Asia) Lexaria Bioscience has announced that a CBD product beats a placebo in simulating acute pulmonary hypertension.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

Journal of Cardiovascular Pharmacology

OCTOBER 30, 2023

Abstract: Pulmonary artery hypertension (PAH) is characterized by pulmonary arterial endothelial cells (PAECs) dysfunction and pulmonary artery smooth muscle cells (PASMCs) activation. Copyright © 2023 Wolters Kluwer Health, Inc. For decades, the therapies for PAH based on stem cells have been shown to be effective.

Pulmonary 40

Pulmonary Hypertension Article 40

DAIC

DECEMBER 29, 2023

Patients in the study will be randomized to undergo pulmonary vein isolation (PVI) and left atrial posterior wall ablation using the FARAPULSE PFA System, or receive AAD treatment, and followed for three years. The randomized AVANT GUARD trial will enroll more than 500 patients diagnosed with persistent AF at up to 75 sites globally.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Circulation

NOVEMBER 11, 2024

Animal studies have shown that mice with TBX1 gene mutations have smaller left pulmonary arteries compared to wild type mice, defined by a reduced left pulmonary artery (LPA) to right pulmonary artery (RPA) ratio. A single study has shown this translates to humans with 22q11 and structurally normal hearts.

Pulmonary 40

Pulmonary Risk Factors Heart Disease Echocardiogram 40

DAIC

DECEMBER 14, 2023

The PulseSelect PFA system was engineered with differentiated safety features and provides rapid, effective pulmonary vein isolation (PVI) through consistent and predictable energy delivery and catheter maneuverability. November 2023. The system is designed to enable a seamless transition to PFA in a clinician's preferred workflow 2.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Cox regression was used to evaluate the association between palliation strategy and 6-month mortality.Results:From 2021 to 2023, 17 patients (median age, 4 days; interquartile range [IQR], 2–8; median weight, 2.5

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

The American Journal of Cardiology

DECEMBER 31, 2023

Publication date: Available online 30 December 2023 Source: The American Journal of Cardiology Author(s): Tanmay Gokhale, Matthew E. Harinstein

Pulmonary 40

Pulmonary Hypertension 40

Ken Grauer, MD

AUGUST 16, 2024

For a 10-minute video review on reading Pulmonary CT Scan — WATCH_this_VIDEO by Dr. Jake Gibbons. Figure-5: CTPA view in today's case — showing large clot burden in the right and left main pulmonary arteries. == C ASE F ollow-Up: The "good news" in today's case — is that the patient received thrombolytics, and ultimately did well.

Blog 152

Blog Tachycardia Cardiogenic Shock Pulmonary 152

Dr. Smith's ECG Blog

SEPTEMBER 17, 2023

large ASD, partial anomalous pulmonary venous return, significant tricuspid regurgitation, carcinoid valvular disease, etc,) 2) Conditions causing pressure overload of the RV. Any cause of pulmonary hypertension. There is normal axis, normal R-wave progression in the precordial leads and no intraventricular conduction abnormalities.

Pulmonary 116

Pulmonary Tricuspid Chest Pain Cardiogenic Shock 116

Journal of Cardiovascular Pharmacology

DECEMBER 25, 2023

Shortness of breath and syncope are common symptoms of right ventricular failure caused by pulmonary arterial hypertension (PAH), which is the result of blockage and increased pressure in the pulmonary arteries. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Pulmonary 40

Pulmonary Hypertension Research Article 40

DAIC

DECEMBER 19, 2023

Getty Images milla1cf Tue, 12/19/2023 - 18:09 December 19, 2023 — BioCardia, Inc. , These trials included 93 patients treated with culture expanded MSCs or dedicated controls using the Helix delivery system with no observed treatment emergent serious adverse events.

Heart Failure 105

Heart Failure Interventional Cardiology Pulmonary Heart Disease 105

Dr. Smith's ECG Blog

JANUARY 20, 2024

CT pulmonary angiogram (unnecessary, often done while missing OMI) was unremarkable. Instead, pain is numbed and thus ischemia is obscured with opioids, excuses like hypertension are blamed, and unnecessary CT pulmonary angiograms are focused on. Which is true. The initial high sensitivity troponin I returned at around 3300 ng/L.

Chest Pain 121

Chest Pain STEMI Hypertension Blog 121

Frontiers in Cardiovascular Medicine

OCTOBER 13, 2024

A comparison between SSc patients with PAH (SSc-PAH) and those with PH and significant ILD (SSc-PH) was also carried out.Materials and methodsA retrospective single-center study in which all patients having SSc—complicated by PH—referring to the Scleroderma-Unit of the AOU Policlinico of Modena, from October 2013 to October 2023 were evaluated.

Pulmonary 52

Pulmonary Hypertension Risk Factors 52

Ken Grauer, MD

SEPTEMBER 22, 2023

KEY Point: Although true that patients with longstanding, severe pulmonary disease may manifest a QRST complex in standard lead I with marked overall reduction in QRST amplitude ( See ECG Blog #65 — regarding Schamroth’s Sign ) — you should never normally see a completely flat line in any of the standard limb leads.

Blog 178

Blog Chest Pain Bradycardia Physiology 178

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 3, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. BACKGROUND:In patients with persistent atrial fibrillation (PersAF), catheter ablation aiming for pulmonary vein isolation (PVI) is associated with moderate clinical effectiveness.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Quality of Life Ablation 40

Stroke Journal

FEBRUARY 1, 2024

Background:Chronic obstructive pulmonary disorder (COPD) is a progressive respiratory disorder ranking third in global mortality. The search timeline included the earliest available date until April 2023, including studies that investigated stroke occurrence in COPD patients. The analysis was conducted using CMA v.3

Pulmonary 40

Pulmonary Stroke Strokes 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 30 November 2023 Source: The American Journal of Cardiology Author(s): Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Javier Jimenez, Shebin George, Jiana Baker, Juan Ruiz, Sandra Chaparro

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Hypertension Hospital 40

Ken Grauer, MD

FEBRUARY 28, 2023

These 2 settings are: i ) In patients with severe , often longstanding pulmonary disease ; and / or , ii ) In acutely ill patients with multi-system disease ( ie, sepsis, shock, electrolyte and/or acid-base disorders ). Hypoxic injury ( from pneumonia or other acute pulmonary complication ). Acute pulmonary embolus.

Blog 78

Blog COVID-19 AFIB Pulmonary 78

DAIC

FEBRUARY 22, 2024

El-Hamamsy is a recognized expert in aortic surgery, including the Ross procedure, and led a team of Mount Sinai cardiovascular surgeons to perform more than 100 successful Ross procedures in 2023—the first time any surgical program in the world has achieved this milestone in a single year.

Heart Valves 142

Heart Valves Aortic valve Aortic Sudden Cardiac Death 142